Comparison of Preloading vs. Co-loading With Crystalloids to Prevent Spinal Anaesthesia-Induced Hypotension
The purpose of this study is to compare the effectiveness of crystalloid pre-load with co-load intravenous fluid in the prevention of spinal anaesthesia-induced hypotension during elective caesarean sections and to assess the incidence of nausea, vomiting, bradycardia, and the requirement for vasopressors.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Erbil, Iraq
- Erbil maternaty hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged 18-40 years.
- elective caesarean.
- singleton pregnancy.
- American Society of Anaesthesiologists (ASA) classification of class I or II.
Exclusion Criteria:
- Pregnancy-induced hypertension or preeclampsia.
- multiple pregnancies.
- BMI greater than 35 kg/m².
- contraindications to spinal anaesthesia.
- emergency caesarean sections.
- past medical history of cardiovascular disease and diabetes mellitus.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Maternal hpotension
|
The pre-load group received Ringer lactate 15 mL/kg over 15-20 minutes before induction of spinal anaesthesia, the co-load group received Ringer lactate 15 mL/kg immediately after intrathecal injection. |
|
Active Comparator: No maternal hypotension
|
The pre-load group received Ringer lactate 15 mL/kg over 15-20 minutes before induction of spinal anaesthesia, the co-load group received Ringer lactate 15 mL/kg immediately after intrathecal injection. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Spinal Anaesthesia-Induced Hypotension
Time Frame: Through surgery completion, an average of 20 mins
|
Proportion of participants who develop hypotension following spinal anaesthesia in the preloading and co-loading groups. |
Through surgery completion, an average of 20 mins
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- Erbil maternity hospital
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.